BENEDETTA GHEZZI

Dr. BENEDETTA GHEZZI

Medicine and Surgery, Centre of Dental Medicine, University of Parma, Parma, Emilia-Romagna, Italy
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Japanese Dental Science Review
Verified
Journal Article
Open access
LPLudovica Parisi
Ludovica Parisi
Andrea ToffoliAndrea Toffoli
Andrea Toffoli
BGBENEDETTA GHEZZI
BENEDETTA GHEZZI
BMBeatrice Mozzoni
Beatrice Mozzoni
SLSimone Lumetti
Simone Lumetti
GMGuido M. Macaluso
Guido M. Macaluso
The bioactivity of biomaterials is closely related to cell response in contact with them. However, shortly after their insertion, materials are soon covered with proteins that constitute the biological fluids, and which render the direct surface recognition by cells almost impossible. The control of protein adsorption at the interface is therefore desirable. Extracellular matrix proteins are of particular interest in this sense, due to their well-known ability to modulate cell behavior. Particularly, fibronectin plays a leading role, being present in both healthy and injured tissues undergoing healing and regeneration. The aim of the present work is to give an overview on fibronectin and on its involvement in the control of cell behavior providing evidence of its pivotal role in the control of cell adhesion, spreading, migration, proliferation and differentiation. A deep insight into methods to enrich biomaterials surface with fibronectin will be then discussed, as well as new cues on the possibility to design tailored platforms able to specifically retain fibronectin from the surrounding extracellular milieu.

9 February 2024 in Bioengineering
Verified
Journal Article
Open access
PDF file
GGGiuseppe De Giorgio
Giuseppe De Giorgio
BMBiagio Matera
Biagio Matera
DVDavide Vurro
Davide Vurro
EMEdoardo Manfredi
Edoardo Manfredi
Vardan GalstyanVardan Galstyan
Vardan Galstyan
Pasquale D'AngeloPasquale D'Angelo
Pasquale D'Angelo
The golden rule in tissue engineering is the creation of a synthetic device that simulates the native tissue, thus leading to the proper restoration of its anatomical and functional integrity, avoiding the limitations related to approaches based on autografts and allografts. The emergence of synthetic biocompatible materials has led to the production of innovative scaffolds that, if combined with cells and/or bioactive molecules, can improve tissue regeneration. In the last decade, silk fibroin (SF) has gained attention as a promising biomaterial in regenerative medicine due to its enhanced bio/cytocompatibility, chemical stability, and mechanical properties. Moreover, the possibility to produce advanced medical tools such as films, fibers, hydrogels, 3D porous scaffolds, non-woven scaffolds, particles or composite materials from a raw aqueous solution emphasizes the versatility of SF. Such devices are capable of meeting the most diverse tissue needs; hence, they represent an innovative clinical solution for the treatment of bone/cartilage, the cardiovascular system, neural, skin, and pancreatic tissue regeneration, as well as for many other biomedical applications. The present narrative review encompasses topics such as (i) the most interesting features of SF-based biomaterials, bare SF’s biological nature and structural features, and comprehending the related chemo-physical properties and techniques used to produce the desired formulations of SF; (ii) the different applications of SF-based biomaterials and their related composite structures, discussing their biocompatibility and effectiveness in the medical field. Particularly, applications in regenerative medicine are also analyzed herein to highlight the different therapeutic strategies applied to various body sectors.

1 December 2020 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
LPLudovica Parisi
Ludovica Parisi
BGBENEDETTA GHEZZI
BENEDETTA GHEZZI
MBMassimiliano G. Bianchi
Massimiliano G. Bianchi
Andrea ToffoliAndrea Toffoli
Andrea Toffoli
Francesca RossiFrancesca Rossi
Francesca Rossi
Guido Maria MacalusoGuido Maria Macaluso
Guido Maria Macaluso

6 August 2020 in Metabolites
Verified
Journal Article
Open access
PDF file
Marco MeletiMarco Meleti
Marco Meleti
EQEleonora Quartieri
Eleonora Quartieri
RARita Antonelli
Rita Antonelli
MPMargherita Eleonora Pezzi
Margherita Eleonora Pezzi
BGBENEDETTA GHEZZI
BENEDETTA GHEZZI
TPThelma Pertinhez
Thelma Pertinhez
The detection of salivary molecules associated with pathological and physiological alterations has encouraged the search of novel and non-invasive diagnostic biomarkers for oral health evaluation. While genomic, transcriptomic, and proteomic profiles of human saliva have been reported, its metabolic composition is a topic of research: metabolites in submandibular/sublingual saliva have never been analyzed systematically. In this study, samples of whole, parotid, and submandibular/sublingual saliva from 20 healthy donors, without dental or periodontal diseases, were examined by nuclear magnetic resonance. We identified metabolites which are differently distributed within the three saliva subtypes (54 in whole, 49 in parotid, and 36 in submandibular/sublingual saliva). Principal component analysis revealed a distinct cluster for whole saliva and a partial overlap for parotid and submandibular/sublingual metabolites. We found exclusive metabolites for each subtype: 2-hydroxy-3-methylvalerate, 3-methyl-glutarate, 3-phenylpropionate, 4-hydroxyphenylacetate, 4-hydroxyphenyllactate, galactose, and isocaproate in whole saliva; caprylate and glycolate in submandibular/sublingual saliva; arginine in parotid saliva. Salivary metabolites were classified into standard and non-proteinogenic amino acids and amines; simple carbohydrates; organic acids; bacterial-derived metabolites. The identification of a salivary gland-specific metabolic composition in healthy people provides the basis to invigorate the search for salivary biomarkers associated with oral and systemic diseases.

13 April 2024 in International Dental Journal
Verified
Journal Article
Open access
BGBENEDETTA GHEZZI
BENEDETTA GHEZZI
BMBiagio Matera
Biagio Matera
MMMatteo Meglioli
Matteo Meglioli
FRFrancesca Rossi
Francesca Rossi
DDDonatella Duraccio
Donatella Duraccio
SLSimone Lumetti
Simone Lumetti
The purpose of this work was to optimise printable polycaprolactone (PCL)/β-tricalcium phosphate (β-TCP) biomaterials with high percentages of β-TCP endowed with balanced mechanical characteristics to resemble human cancellous bone, presumably improving osteogenesis. PCL/β-TCP scaffolds were obtained from customised filaments for fused deposition modelling (FDM) 3D printing with increasing amounts of β-TCP. Samples mechanical features, surface topography and wettability were evaluated as well as cytocompatibility assays, cell adhesion and differentiation. The parameters of the newly fabricated materila were optimal for PCL/β-TCP scaffold fabrication. Composite surfaces showed higher hydrophilicity compared with the controls, and their surface roughness sharply was higher, possibly due to the presence of β-TCP. The Young's modulus of the composites was significantly higher than that of pristine PCL, indicating that the intrinsic strength of β-TCP is beneficial for enhancing the elastic modulus of the composite biomaterials. All novel composite biomaterials supported greater cellular growth and stronger osteoblastic differentiation compared with the PCL control. This project highlights the possibility to fabricat, through an FDM solvent-free approach, PCL/β-TCP scaffolds of up to 70 % concentrations of β-TCP. overcoming the current lmit of 60 % stated in the literature. The combination of 3D printing and customised biomaterials allowed production of highly personalised scaffolds with optimal mechanical and biological features resembling the natural structure and the composition of bone. This underlines the promise of such structures for innovative approaches for bone and periodontal regeneration.

14 September 2016 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
TRTiziano Rimoldi
Tiziano Rimoldi
DODavide Orsi
Davide Orsi
PLPaola Lagonegro
Paola Lagonegro
BGBENEDETTA GHEZZI
BENEDETTA GHEZZI
Carlo GalliCarlo Galli
Carlo Galli
LCLuigi Cristofolini
Luigi Cristofolini